Key result
Combined mean platelet volume and platelet distribution width was not associated with the prevalence of coronary artery disease (adjusted OR 0.95; 95% CI 0.85-1.05; P=0.3).
Why the study?
Does the combination of mean platelet volume and platelet distribution width predict the prevalence and extent of coronary artery disease in patients undergoing coronary angiography?
Cross-Sectional (n=2,330)
Does the combination of mean platelet volume and platelet distribution width predict the prevalence and extent of coronary artery disease in patients undergoing coronary angiography?
Odds Ratio: 0.95 (95% CI 0.85–1.05)
p-value: p=0.3
The combination of mean platelet volume and platelet distribution width does not predict the prevalence or extent of coronary artery disease and should not be considered a risk factor.
No association with CAD prevalence warrants no change in risk assessment; leaves open prospective validation of combined MPV and PDW.
The aim of the current study was to investigate whether the combination between mean platelet volume (MPV) and platelet distribution width (PDW) may improve the prognostic information in the prediction of prevalence and extent of coronary artery disease (CAD). We measured MPV and PDW in 2330 consecutive patients undergoing coronary angiography. Significant CAD was defined as stenosis more than 50% in at least one coronary vessel. We additionally measured carotid intima-media thickness (IMT) in 359 patients. Patients were grouped according to the median value of MPV (10.8fl) and PDW (13fl): Group 1 (MPV and PDW < 50th percentile; n = 958); Group 2 (MPV or PDW ≥50th percentile; n = 288); Group 3 (MPW and PDW ≥ 50th percentile; n = 1055). Patients in Group 3 were older (P < 0.001) with larger prevalence of diabetes (P = 0.024). Combined MPV-PWD was significantly associated with baseline glycemia (P < 0.001) and red blood cell count (P < 0.0001), but inversely related to platelet count (P < 0.0001). Combined MPV-PDW was inversely associated with the presence of thrombus, but directly related to the prevalence of chronic occlusion and worse TIMI flow. However, combined MPV-MPV was not associated with the prevalence of CAD [odds ratio (OR) (95% confidence interval (CI) = 0.99 (0.90-1.09), P = 0.87; adjusted OR (95%CI) = 0.95 (0.85-1.05), P = 0.3], or severe CAD [OR (95%CI) = 1.05 (0.95-1.16), P = 0.3; adjusted OR (95% CI) = 0.97 (0.87-1.08), P = 0.63]. No relationship was observed between IMT and the combination of PDW and MPW. This study showed that the combined information on MPV and PDW is not related to the extent of CAD and carotid IMT. Thus, both MPV and PDW can not be considered as a risk factor for CAD.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2013) conducted a cross-sectional in Coronary artery disease (n=2,330). Combined mean platelet volume (MPV) and platelet distribution width (PDW) vs. Lower MPV and PDW was evaluated on Prevalence of coronary artery disease (adjusted OR 0.95, 95% CI 0.85-1.05, p=0.3). Combined mean platelet volume and platelet distribution width was not associated with the prevalence of coronary artery disease (adjusted OR 0.95; 95% CI 0.85-1.05; P=0.3).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: